Latest filing published 11 Dec 2025 for Regeneron Pharmaceuticals, INC., €1.5M.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
Daniel P. Van Plew: trading record in brief
This profile gathers the share dealings of Daniel P. Van Plew in Regeneron Pharmaceuticals, Inc., where the filings describe the role as chief executive. The record holds 265 filings, for trades running from 16 December 2010 to 9 December 2025.
The open-market record consists of 165 sales worth €121.3M, with no purchase. Other entries cover 61 share grants and 39 option exercises.
The newest entry dates from 11 December 2025: a share grant of €1.5M, in Regeneron Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Daniel P. Van Plew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,552 shares@ US$701.511.6% of flowCommon StockSEC:0001411984-25-000007:0
- 1,906 shares@ US$712.940.3% of flowCommon StockSEC:0001411984-25-000005:1
- 3,715 shares0Common StockSEC:0001411984-25-000005:0
- 969 shares@ US$730.810.7% of flowCommon StockSEC:0001968202-24-000142:0
- 492 shares@ US$787.000.1% of flowCommon StockSEC:0001883850-24-000049:1
- 3,499 shares0Common StockSEC:0001883850-24-000049:0
- 226 shares@ US$938.130.0% of flowCommon StockSEC:0001968202-24-000066:1
- 750 shares@ US$939.600.2% of flowCommon StockSEC:0001968202-24-000066:2
- 4,261 shares@ US$940.440.9% of flowCommon StockSEC:0001968202-24-000066:3
- 275 shares@ US$941.410.1% of flowCommon StockSEC:0001968202-24-000066:4
- 2,691 shares@ US$943.510.6% of flowCommon StockSEC:0001968202-24-000066:5
- 620 shares@ US$944.300.1% of flowCommon StockSEC:0001968202-24-000066:6
- 95 shares@ US$945.810.0% of flowCommon StockSEC:0001968202-24-000066:7
- 240 shares@ US$947.810.1% of flowCommon StockSEC:0001968202-24-000066:8
- 150 shares@ US$948.700.0% of flowCommon StockSEC:0001968202-24-000066:9
- 112 shares@ US$949.070.0% of flowCommon StockSEC:0001968202-24-000066:10
- 375 shares@ US$950.450.1% of flowCommon StockSEC:0001968202-24-000066:11
- 200 shares@ US$951.770.0% of flowCommon StockSEC:0001968202-24-000066:12
- 439 shares@ US$937.940.4% of flowCommon StockSEC:0001968202-24-000066:0
- 8,600 shares@ US$951.681.8% of flowCommon StockSEC:0001968202-24-000064:1
- 23,125 shares@ US$381.402.0% of flowCommon StockSEC:0001968202-24-000064:2
- 16,341 shares@ US$951.683.5% of flowCommon StockSEC:0001968202-24-000064:3
- 12,250 shares@ US$372.464.4% of flowCommon StockSEC:0001968202-24-000064:0
- 2,552 shares@ US$844.090.5% of flowCommon StockSEC:0001883850-23-000091:2
- 669 shares@ US$844.090.1% of flowCommon StockSEC:0001883850-23-000091:3
25 of 264 declarations
